Dosimetric advantages of generalised equivalent uniform dose-based optimisation on dose–volume objectives in intensity-modulated radiotherapy planning for bilateral breast cancer-Reference-Cited by-同舟云学术

Dosimetric advantages of generalised equivalent uniform dose-based optimisation on dose–volume objectives in intensity-modulated radiotherapy planning for bilateral breast cancer

Published:2012-11 Issue:1019 Volume:85 Page:1499-1506
ISSN:0007-1285
Container-title:The British Journal of Radiology
language:en
Short-container-title:BJR

Author:

Lee T-F,Ting H-M,Chao P-J,Wang H-Y,Shieh C-S,Horng M-F,Wu J-M,Yeh S-A,Cho M-Y,Huang E-Y,Huang Y-J,Chen H-C,Fang F-M

Publisher

British Institute of Radiology

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://www.birpublications.org/doi/pdf/10.1259/bjr/24112047

Reference34 articles.

1. Global Cancer Statistics, 2002

2. Cancer Statistics, 2006

3. Genome-wide association study identifies novel breast cancer susceptibility loci

4. Bilateral Synchronous Breast Cancer in an Asian Population: Mammographic and Sonographic Characteristics, Detection Methods, and Staging

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study the Quality of Nasopharyngeal plans Using Evaluation Indexes of IMRT and VMAT Treatment planning Techniques;Baghdad Science Journal;2023-07-20

2. Effective optimization strategy for large optimization volume object, remaining volume at risk (RVR): α-value selection and usage from generalized equivalent uniform dose (gEUD) curve deviation perspective;Physics in Medicine & Biology;2023-02-23

3. Potential advantages of gEUD optimisation as compared with conventional physical optimisation for stereotactic treatment planning;Journal of Radiotherapy in Practice;2023

4. Efficacy, safety, and feasibility of volumetric modulated arc therapy for synchronous bilateral breast cancer management;Frontiers in Oncology;2022-08-18

5. Radial Data Mining to Identify Density–Dose Interactions That Predict Distant Failure Following SABR;Frontiers in Oncology;2022-03-09